Large Skin Ulcer Due to a Subcutaneous Orthopaedic Implant After Bevacizumab Therapy: A Case Report
暂无分享,去创建一个
Tsuyoshi Saito | Daisuke Kubota | K. Akaike | Y. Suehara | Kazuo Kaneko | S. Kato | Yu Tanabe | Hideo Ôsawa
[1] M. Ara,et al. Antiangiogenic agents and the skin: cutaneous adverse effects of sorafenib, sunitinib, and bevacizumab. , 2014, Actas dermo-sifiliograficas.
[2] M. Ara,et al. Antiangiogenic agents and the skin: cutaneous adverse effects of sorafenib, sunitinib, and bevacizumab. , 2014, Actas dermo-sifiliograficas.
[3] P. Henry,et al. Rate of and Risk Factors for Reoperations After Open Reduction and Internal Fixation of Midshaft Clavicle Fractures: A Population-Based Study in Ontario, Canada. , 2014, The Journal of bone and joint surgery. American volume.
[4] A. Freedman,et al. Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System Database , 2012, Drug Safety.
[5] O. van der Meijden,et al. Systematic review of the complications of plate fixation of clavicle fractures , 2012, Archives of Orthopaedic and Trauma Surgery.
[6] P. Cottu,et al. Wound healing and catheter thrombosis after implantable venous access device placement in 266 breast cancers treated with bevacizumab therapy , 2011, Anti-cancer drugs.
[7] A. Vincent-Salomon,et al. Necrosis in breast cancer patients with skin metastases receiving bevacizumab-based therapy. , 2011, Journal of wound care.
[8] J. Oh,et al. Treatment of distal clavicle fracture: a systematic review of treatment modalities in 425 fractures , 2011, Archives of Orthopaedic and Trauma Surgery.
[9] G. Giaccone,et al. Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib , 2010, Journal of experimental & clinical cancer research : CR.
[10] L. Ellis,et al. Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care. , 2010, The Lancet. Oncology.
[11] K. Almhanna,et al. Subcutaneous implantable venous access device erosion through the skin in patients treated with anti-vascular endothelial growth factor therapy: a case series. , 2008, Anti-cancer drugs.
[12] S. Natsugoe,et al. Impaired wound healing and expansion of a large ulcer after bevacizumab with paclitaxel for skin metastases from breast cancer: report of a case , 2014, Surgery Today.